LBA-17 MULTICENTER PROSPECTIVE PHASE II CLINICAL TRIAL OF GEMCITABINE AND CISPLATIN AS NEOADJUVANT CHEMOTHERAPY IN PATIENTS WITH HIGH-GRADE UPPER TRACT UROTHELIAL CARCINOMA

Jonathan A. Coleman,Nathan C. Wong,Daniel D. Sjoberg,Nicholas Silva,Bernard H. Bochner,Guido Dalbagni,S. Machele Donat,Harry W. Herr,Eugene Cha,Timothy R. Donahue,Eugene J. Pietzak,Hikmat Al-Ahmadie,Nicole Benfante,Anoop M. Meraney,Steven Shichman,Jeffrey Kamradt,Suresh R. Nair,Angelo A. Baccala,Phillip Abbosh,Paul Palyca,Bradley W. Lash,Muhammad A. Rizvi,Antonio Muina,Min Yuen Teo,Gopa Iyer,Jonathan E. Rosenberg,Dean F. Bajorin

LBA-17 MULTICENTER PROSPECTIVE PHASE II CLINICAL TRIAL OF GEMCITABINE AND CISPLATIN AS NEOADJUVANT CHEMOTHERAPY IN PATIENTS WITH HIGH-GRADE UPPER TRACT UROTHELIAL CARCINOMA

2019

INTRODUCTION AND OBJECTIVES:Neoadjuvant chemotherapy (NAC) has established survival benefits prior to radical cystectomy for invasive urothelial carcinoma, yet its role in managing high risk upper ...

Keywords:

Clinical trial
Carcinoma
Urology
Gemcitabine
Cisplatin
Chemotherapy
Medicine
in patient
upper tract
urothelial carcinoma

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations